Previous 10 | Next 10 |
Summary We think value stocks can outperform as interest rates head higher. Regions and sectors help us find quality within value and growth at a reasonable price. Stocks slid after the Federal Reserve’s preferred inflation gauge showed persistently high inflation, reinforcing wh...
Summary Valneva SE is a French biotechnology company specializing in developing and commercializing vaccines. We expect approval of two attractive vaccine candidates targeting Chikungunya and Lyme disease by 2024-2025. The company has a relatively cheap valuation, enterprise value o...
Summary I'm not buying the “Wishful Disinflation” and “Wishful Pivot” theories regarding Inflation and the Fed. "Fundamentals" and "Technicals" both suggest stocks could stay rangebound in the coming months. The investment backdrop is so fragile any forec...
Summary Launched in June 2011, CURE has a long track record for a leveraged ETF. What makes this 3x leveraged ETF truly unique is its shockingly high multi-year returns. Its recent divergence from the S&P 500 is a "tell" about market conditions. The Healthcare Select Sector ...
Summary This article is built around one key question: Where would you put $10,000 right now? I started by assessing the parameters of this question and presented interesting value-adding answers for my Twitter followers with additional context. In light of this context, I explain w...
Summary Except for "Jobs", economic data dictates the economy is in a state of "contraction" while Inflation remains "sticky". The recent rally is focused on the notion of a soft landing and the impact the China re-opening will have on the global scene. There is nothing in this econ...
Summary The "Glass Half-Full" party continues; don't dismiss the strength of this move. The Yield curve inversion sits at a four-decade high, while the "soft landing" theme gains momentum. The Mini-rally takes a breather. "Change your thoughts and you change your world...
Summary BME is a top healthcare CEF with a long tenure that offers monthly distributions and an average yield. Many of its top individual holdings are currently on dips, making it a good time to consider buying BME. High turnover is a main risk but has not hindered past performance....
Summary The S&P 500 index is almost unarguably the #1 benchmark followed by long-term investors, fundamental analysts, and short-term traders alike. I felt the need to explain 16 details about the S&P 500, I believe well-informed investors should know about this index, however t...
Summary We initiate Xenon Pharmaceuticals with a BUY rating. We see XENE as one of the most de-risked and compelling SMID-cap biotech companies with a lead late-stage clinical candidate. We build a high degree of conviction based on recent phase 2b X-TOLE data that demonstrated a si...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...